{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:11:44Z","timestamp":1784268704813,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12400-x","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:00:52Z","timestamp":1784268052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential NAD\u2009+\u2009availability may drive asymmetric SIRT7 activity in tumor and immune cells"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7730-6452","authenticated-orcid":false,"given":"Francisco Alejandro","family":"Lagunas-Rangel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"12400_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia I, Haigis MC (2021) Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab 3:21\u201332. https:\/\/doi.org\/10.1038\/s42255-020-00317-z","journal-title":"Nat Metab"},{"key":"12400_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc.2016.84","volume":"16","author":"MS Nakazawa","year":"2016","unstructured":"Nakazawa MS, Keith B, Simon MC (2016) Oxygen availability and metabolic adaptations. Nat Rev Cancer 16:663\u2013673. https:\/\/doi.org\/10.1038\/nrc.2016.84","journal-title":"Nat Rev Cancer"},{"key":"12400_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11738-0","volume":"10","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Dai Z, Locasale JW (2019) Metabolic landscape of the tumor microenvironment at single cell resolution. Nat Commun 10:3763. https:\/\/doi.org\/10.1038\/s41467-019-11738-0","journal-title":"Nat Commun"},{"key":"12400_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature19364","volume":"537","author":"R Eil","year":"2016","unstructured":"Eil R, Vodnala SK, Clever D et al (2016) Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 537:539\u2013543. https:\/\/doi.org\/10.1038\/nature19364","journal-title":"Nature"},{"key":"12400_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cmet.2019.04.003","volume":"30","author":"S Kumar","year":"2019","unstructured":"Kumar S, Sharife H, Kreisel T et al (2019) Intra-tumoral metabolic zonation and resultant phenotypic diversification are dictated by blood vessel proximity. Cell Metab 30:201-211.e6. https:\/\/doi.org\/10.1016\/j.cmet.2019.04.003","journal-title":"Cell Metab"},{"key":"12400_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00018-022-04342-x","volume":"79","author":"FA Lagunas-Rangel","year":"2022","unstructured":"Lagunas-Rangel FA (2022) SIRT7 in the aging process. Cell Mol Life Sci 79:297. https:\/\/doi.org\/10.1007\/s00018-022-04342-x","journal-title":"Cell Mol Life Sci"},{"key":"12400_CR7","doi-asserted-by":"publisher","first-page":"8081","DOI":"10.1080\/07391102.2022.2126890","volume":"41","author":"FA Lagunas-Rangel","year":"2023","unstructured":"Lagunas-Rangel FA (2023) Bioinformatic analysis of SIRT7 sequence and structure. J Biomol Struct Dyn 41:8081\u20138091. https:\/\/doi.org\/10.1080\/07391102.2022.2126890","journal-title":"J Biomol Struct Dyn"},{"key":"12400_CR8","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11010-023-04869-y","volume":"479","author":"FA Lagunas-Rangel","year":"2024","unstructured":"Lagunas-Rangel FA (2024) The dark side of SIRT7. Mol Cell Biochem 479:2843\u20132861. https:\/\/doi.org\/10.1007\/s11010-023-04869-y","journal-title":"Mol Cell Biochem"},{"key":"12400_CR9","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41418-025-01490-y","volume":"32","author":"Z Hu","year":"2025","unstructured":"Hu Z, Chen Y, Lei J et al (2025) SIRT7 regulates T-cell antitumor immunity through modulation BCAA and fatty acid metabolism. Cell Death Differ 32:1777\u20131790. https:\/\/doi.org\/10.1038\/s41418-025-01490-y","journal-title":"Cell Death Differ"},{"key":"12400_CR10","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.28.4.899","author":"S Voelter-Mahlknecht","year":"2006","unstructured":"Voelter-Mahlknecht S, Letzel S, Mahlknecht U (2006) Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.28.4.899","journal-title":"Int J Oncol"},{"key":"12400_CR11","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbapap.2009.09.009","volume":"1804","author":"BD Sanders","year":"2010","unstructured":"Sanders BD, Jackson B, Marmorstein R (2010) Structural basis for sirtuin function: what we know and what we don\u2019t. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1804:1604\u20131616. https:\/\/doi.org\/10.1016\/j.bbapap.2009.09.009","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"key":"12400_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz2590","volume":"6","author":"NG Simonet","year":"2020","unstructured":"Simonet NG, Thackray JK, Vazquez BN et al (2020) Sirt7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1. Sci Adv 6:eaaz2590. https:\/\/doi.org\/10.1126\/sciadv.aaz2590","journal-title":"Sci Adv"},{"key":"12400_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1021\/acschembio.6b00954","volume":"12","author":"Z Tong","year":"2017","unstructured":"Tong Z, Wang M, Wang Y et al (2017) SIRT7 is an RNA-activated protein lysine deacylase. ACS Chem Biol 12:300\u2013310. https:\/\/doi.org\/10.1021\/acschembio.6b00954","journal-title":"ACS Chem Biol"},{"key":"12400_CR14","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1111\/febs.12346","volume":"280","author":"S Kiran","year":"2013","unstructured":"Kiran S, Chatterjee N, Singh S et al (2013) Intracellular distribution of human SIRT 7 and mapping of the nuclear\/nucleolar localization signal. FEBS J 280:3451\u20133466. https:\/\/doi.org\/10.1111\/febs.12346","journal-title":"FEBS J"},{"key":"12400_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41388-024-02976-8","volume":"43","author":"A Ianni","year":"2024","unstructured":"Ianni A, Kumari P, Tarighi S et al (2024) SIRT7: a novel molecular target for personalized cancer treatment? Oncogene 43:993\u20131006. https:\/\/doi.org\/10.1038\/s41388-024-02976-8","journal-title":"Oncogene"},{"key":"12400_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.dnarep.2019.06.009","volume":"80","author":"FA Lagunas-Rangel","year":"2019","unstructured":"Lagunas-Rangel FA (2019) Current role of mammalian sirtuins in DNA repair. DNA Repair 80:85\u201392. https:\/\/doi.org\/10.1016\/j.dnarep.2019.06.009","journal-title":"DNA Repair"},{"key":"12400_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav1118","volume":"5","author":"M Tang","year":"2019","unstructured":"Tang M, Li Z, Zhang C et al (2019) SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair. Sci Adv 5:eaav1118. https:\/\/doi.org\/10.1126\/sciadv.aav1118","journal-title":"Sci Adv"},{"key":"12400_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104145","volume":"92","author":"J Li","year":"2026","unstructured":"Li J, Zhang T, Ma T et al (2026) Why is the tumor microenvironment disordered by NADH\/NAD+ imbalance and how can we intervene? Redox Biol 92:104145. https:\/\/doi.org\/10.1016\/j.redox.2026.104145","journal-title":"Redox Biol"},{"key":"12400_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073153","volume":"26","author":"MG Kibria","year":"2025","unstructured":"Kibria MG, Yoshizawa T, Zhang T et al (2025) SIRT7 is a lysine deacylase with a preference for depropionylation and demyristoylation. IJMS 26:3153. https:\/\/doi.org\/10.3390\/ijms26073153","journal-title":"IJMS"},{"key":"12400_CR20","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1126\/science.aad5168","volume":"352","author":"XA Cambronne","year":"2016","unstructured":"Cambronne XA, Stewart ML, Kim D et al (2016) Biosensor reveals multiple sources for mitochondrial NAD+. Science 352:1474\u20131477. https:\/\/doi.org\/10.1126\/science.aad5168","journal-title":"Science"},{"key":"12400_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658263","volume":"12","author":"F Morandi","year":"2021","unstructured":"Morandi F, Horenstein AL, Malavasi F (2021) The key role of NAD+ in anti-tumor immune response: an update. Front Immunol 12:658263. https:\/\/doi.org\/10.3389\/fimmu.2021.658263","journal-title":"Front Immunol"},{"key":"12400_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s42255-018-0009-4","volume":"1","author":"A Grozio","year":"2019","unstructured":"Grozio A, Mills KF, Yoshino J et al (2019) Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab 1:47\u201357. https:\/\/doi.org\/10.1038\/s42255-018-0009-4","journal-title":"Nat Metab"},{"key":"12400_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cmet.2020.10.021","volume":"24","author":"P-S Liu","year":"2023","unstructured":"Liu P-S, Chen Y-T, Li X, et al (2023) CD40 signal rewires fatty acid and glutamine metabolismfor stimulating macrophage anti-tumorigenic functions. Nat Immunol 24:452\u2013462. https:\/\/doi.org\/10.1038\/s41590-023-01430-3","journal-title":"Nat Immunol"},{"key":"12400_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrc3340","volume":"12","author":"A Chiarugi","year":"2012","unstructured":"Chiarugi A, D\u00f6lle C, Felici R, Ziegler M (2012) The NAD metabolome \u2014 a key determinant of cancer cell biology. Nat Rev Cancer 12:741\u2013752. https:\/\/doi.org\/10.1038\/nrc3340","journal-title":"Nat Rev Cancer"},{"key":"12400_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109516","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang F, Wang L et al (2021) NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells. Cell Rep 36:109516. https:\/\/doi.org\/10.1016\/j.celrep.2021.109516","journal-title":"Cell Rep"},{"key":"12400_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.32658","volume":"78","author":"X Guo","year":"2023","unstructured":"Guo X, Tan S, Wang T et al (2023) NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity. Hepatology 78:468\u2013485. https:\/\/doi.org\/10.1002\/hep.32658","journal-title":"Hepatology"},{"key":"12400_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41392-023-01314-w","volume":"8","author":"X Yi","year":"2023","unstructured":"Yi X, Wang H, Yang Y et al (2023) SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation. Sig Transduct Target Ther 8:107. https:\/\/doi.org\/10.1038\/s41392-023-01314-w","journal-title":"Sig Transduct Target Ther"},{"key":"12400_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0342269","volume":"21","author":"KMT Islam","year":"2026","unstructured":"Islam KMT, Mahmud S (2026) SIRT7 as a context-dependent biomarker and therapeutic target: insights from a pan-cancer study. PLoS ONE 21:e0342269. https:\/\/doi.org\/10.1371\/journal.pone.0342269","journal-title":"PLoS ONE"},{"key":"12400_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00621","volume":"10","author":"Q Huo","year":"2020","unstructured":"Huo Q, Li Z, Cheng L et al (2020) SIRT7 is a prognostic biomarker associated with immune infiltration in luminal breast cancer. Front Oncol 10:621. https:\/\/doi.org\/10.3389\/fonc.2020.00621","journal-title":"Front Oncol"},{"key":"12400_CR30","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2147\/IJGM.S353610","volume":"15","author":"W Zhang","year":"2022","unstructured":"Zhang W, Qian Y, Jin X et al (2022) SIRT7 is a prognostic biomarker in kidney renal clear cell carcinoma that is correlated with immune cell infiltration. Int J Gen Med 15:3167\u20133182. https:\/\/doi.org\/10.2147\/IJGM.S353610","journal-title":"Int J Gen Med"},{"key":"12400_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM et al (2015) Tissue-based map of the human proteome. Science 347:1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"key":"12400_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1242\/jcs.042382","volume":"122","author":"A Grob","year":"2009","unstructured":"Grob A, Roussel P, Wright JE et al (2009) Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis. J Cell Sci 122:489\u2013498. https:\/\/doi.org\/10.1242\/jcs.042382","journal-title":"J Cell Sci"},{"key":"12400_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.molcel.2013.10.010","volume":"52","author":"S Chen","year":"2013","unstructured":"Chen S, Seiler J, Santiago-Reichelt M et al (2013) Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7. Mol Cell 52:303\u2013313. https:\/\/doi.org\/10.1016\/j.molcel.2013.10.010","journal-title":"Mol Cell"},{"key":"12400_CR34","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/j.celrep.2018.11.051","volume":"25","author":"A Iyer-Bierhoff","year":"2018","unstructured":"Iyer-Bierhoff A, Krogh N, Tessarz P et al (2018) SIRT7-dependent deacetylation of fibrillarin controls histone H2A methylation and rRNA synthesis during the cell cycle. Cell Rep 25:2946-2954.e5. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.051","journal-title":"Cell Rep"},{"key":"12400_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10734","volume":"7","author":"S Chen","year":"2016","unstructured":"Chen S, Blank MF, Iyer A et al (2016) SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing. Nat Commun 7:10734. https:\/\/doi.org\/10.1038\/ncomms10734","journal-title":"Nat Commun"},{"key":"12400_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12235","volume":"7","author":"L Li","year":"2016","unstructured":"Li L, Shi L, Yang S et al (2016) SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability. Nat Commun 7:12235. https:\/\/doi.org\/10.1038\/ncomms12235","journal-title":"Nat Commun"},{"key":"12400_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.15252\/embj.201593499","volume":"35","author":"BN Vazquez","year":"2016","unstructured":"Vazquez BN, Thackray JK, Simonet NG et al (2016) SIRT 7 promotes genome integrity and modulates non-homologous end joining DNA repair. EMBO J 35:1488\u20131503. https:\/\/doi.org\/10.15252\/embj.201593499","journal-title":"EMBO J"},{"key":"12400_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.yexcr.2014.11.001","volume":"331","author":"S Kiran","year":"2015","unstructured":"Kiran S, Oddi V, Ramakrishna G (2015) Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response. Exp Cell Res 331:123\u2013141. https:\/\/doi.org\/10.1016\/j.yexcr.2014.11.001","journal-title":"Exp Cell Res"},{"key":"12400_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","volume":"62","author":"J-P Etchegaray","year":"2016","unstructured":"Etchegaray J-P, Mostoslavsky R (2016) Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes. Mol Cell 62:695\u2013711. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.029","journal-title":"Mol Cell"},{"key":"12400_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/cells13010048","volume":"13","author":"K Yamagata","year":"2023","unstructured":"Yamagata K, Mizumoto T, Yoshizawa T (2023) The emerging role of SIRT7 in glucose and lipid metabolism. Cells 13:48. https:\/\/doi.org\/10.3390\/cells13010048","journal-title":"Cells"},{"key":"12400_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181\u2013193. https:\/\/doi.org\/10.1038\/nrc2809","journal-title":"Nat Rev Cancer"},{"key":"12400_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92\u2013101. https:\/\/doi.org\/10.1038\/nature13479","journal-title":"Nature"},{"key":"12400_CR43","doi-asserted-by":"publisher","DOI":"10.34133\/research.0808","volume":"8","author":"J Wang","year":"2025","unstructured":"Wang J, Tian H, Gao Y et al (2025) Dual roles of SIRT7 inhibition by Oroxylin A reprogram HSCs fate: PRMT5 succinylation-driven senescence and ecto-calreticulin-dependent NK cell immune clearance in liver fibrosis. Research 8:0808. https:\/\/doi.org\/10.34133\/research.0808","journal-title":"Research"},{"key":"12400_CR44","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/s41590-024-01995-7","volume":"25","author":"A Gamez-Garcia","year":"2024","unstructured":"Gamez-Garcia A, Espinosa-Alcantud M, Bueno-Costa A et al (2024) A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5. Nat Immunol 25:2308\u20132319. https:\/\/doi.org\/10.1038\/s41590-024-01995-7","journal-title":"Nat Immunol"},{"key":"12400_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00460-1","volume":"11","author":"E Zhang","year":"2023","unstructured":"Zhang E, Ding C, Li S et al (2023) Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy. Biomark Res 11:28. https:\/\/doi.org\/10.1186\/s40364-023-00460-1","journal-title":"Biomark Res"},{"key":"12400_CR46","doi-asserted-by":"publisher","unstructured":"Calder\u00f3n L, Schindler K, Malin SG, et al (2021) Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation. Sci Immunol 6:eabg5003. https:\/\/doi.org\/10.1126\/sciimmunol.abg5003","DOI":"10.1126\/sciimmunol.abg5003"},{"key":"12400_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.10.039","volume":"525","author":"F Wu","year":"2022","unstructured":"Wu F, Xu L, Tu Y et al (2022) Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis. Cancer Lett 525:115\u2013130. https:\/\/doi.org\/10.1016\/j.canlet.2021.10.039","journal-title":"Cancer Lett"},{"key":"12400_CR48","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.gastro.2019.10.025","volume":"158","author":"J Xiang","year":"2020","unstructured":"Xiang J, Zhang N, Sun H et al (2020) Disruption of SIRT7 increases the efficacy of checkpoint inhibitor via MEF2D regulation of programmed cell death 1 ligand 1 in hepatocellular carcinoma cells. Gastroenterology 158:664-678.e24. https:\/\/doi.org\/10.1053\/j.gastro.2019.10.025","journal-title":"Gastroenterology"},{"key":"12400_CR49","doi-asserted-by":"publisher","first-page":"17769","DOI":"10.1074\/jbc.RA118.003629","volume":"293","author":"H Qi","year":"2018","unstructured":"Qi H, Shi X, Yu M et al (2018) Sirtuin 7\u2013mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77\/PRMT5 transmethylase complex activity. J Biol Chem 293:17769\u201317779. https:\/\/doi.org\/10.1074\/jbc.RA118.003629","journal-title":"J Biol Chem"},{"key":"12400_CR50","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/s41401-021-00841-y","volume":"43","author":"H Yuan","year":"2022","unstructured":"Yuan H, Zhao M, Zhao L et al (2022) PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours. Acta Pharmacol Sin 43:2373\u20132385. https:\/\/doi.org\/10.1038\/s41401-021-00841-y","journal-title":"Acta Pharmacol Sin"},{"key":"12400_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1579054","volume":"15","author":"FA Lagunas-Rangel","year":"2025","unstructured":"Lagunas-Rangel FA (2025) Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications. Front Oncol 15:1579054. https:\/\/doi.org\/10.3389\/fonc.2025.1579054","journal-title":"Front Oncol"},{"key":"12400_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/diseases14070246","volume":"14","author":"FA Lagunas-Rangel","year":"2026","unstructured":"Lagunas-Rangel FA (2026) Cholesterol reprogramming in acute myeloid leukemia: integrating tumor-intrinsic metabolism and immune crosstalk. Diseases 14:246. https:\/\/doi.org\/10.3390\/diseases14070246","journal-title":"Diseases"},{"key":"12400_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.813233","volume":"9","author":"C Zhang","year":"2022","unstructured":"Zhang C, Li Y, Liu B et al (2022) Discovery of SIRT7 inhibitor as new therapeutic options against liver cancer. Front Cell Dev Biol 9:813233. https:\/\/doi.org\/10.3389\/fcell.2021.813233","journal-title":"Front Cell Dev Biol"},{"key":"12400_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/ph16010119","volume":"16","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhong W, Cao Y et al (2023) Sorafenib\/2800Z co-loaded into cholesterol and PEG grafted polylysine NPs for liver cancer treatment. Pharmaceuticals (Basel) 16:119. https:\/\/doi.org\/10.3390\/ph16010119","journal-title":"Pharmaceuticals (Basel)"},{"key":"12400_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110014","volume":"27","author":"T-S Kang","year":"2024","unstructured":"Kang T-S, Yan Y-M, Tian Y et al (2024) YZL-51N functions as a selective inhibitor of SIRT7 by NAD+ competition to impede DNA damage repair. iScience 27:110014. https:\/\/doi.org\/10.1016\/j.isci.2024.110014","journal-title":"iScience"},{"key":"12400_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.phrs.2016.10.027","volume":"114","author":"BE Kennedy","year":"2016","unstructured":"Kennedy BE, Sharif T, Martell E et al (2016) NAD+ salvage pathway in cancer metabolism and therapy. Pharmacol Res 114:274\u2013283. https:\/\/doi.org\/10.1016\/j.phrs.2016.10.027","journal-title":"Pharmacol Res"},{"key":"12400_CR57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/13543776.2024.2367006","volume":"34","author":"M Gasparrini","year":"2024","unstructured":"Gasparrini M, Giovannuzzi S, Nocentini A et al (2024) Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Expert Opin Ther Pat 34:565\u2013582. https:\/\/doi.org\/10.1080\/13543776.2024.2367006","journal-title":"Expert Opin Ther Pat"},{"key":"12400_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101400","volume":"5","author":"Y Huang","year":"2024","unstructured":"Huang Y, Shao M, Teng X et al (2024) Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism. Cell Rep Med 5:101400. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101400","journal-title":"Cell Rep Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12400-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:00:53Z","timestamp":1784268053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12400-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12400"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12400-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted tools were employed exclusively for linguistic editing and stylistic refinement. All concepts, data, analyses, interpretations, and conclusions are original and were developed independently by the author.","order":3,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1192"}}